Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of an Osteoconductive Scaffold in ACL-Reconstruction

NCT: NCT03462823 · COMPLETED

NCT IDNCT03462823
StatusCOMPLETED
Start Date2017-04-29
Completion2025-04-11
SponsorSandro Fucentese (OTHER)
First posted
Last updated

Brief Summary

Primary objective of the study is to evaluate efficacy of the surgical technique for ACL reconstruction using an osteoconductive scaffold, enlaced into the hamstring tendon autograft, compared to the traditional technique.

Frequently Asked Questions

What is Use of an Osteoconductive Scaffold in ACL-Reconstruction?

Use of an Osteoconductive Scaffold in ACL-Reconstruction is a clinical trial registered under NCT03462823. Current status: COMPLETED.

What is the status of NCT03462823?

The current status of NCT03462823 (Use of an Osteoconductive Scaffold in ACL-Reconstruction) is: COMPLETED.

When did Use of an Osteoconductive Scaffold in ACL-Reconstruction start?

Use of an Osteoconductive Scaffold in ACL-Reconstruction started on 2017-04-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.